|Title:||Method for treating taxol side-effects with G-CSF|
|Abstract:||A method of treating a host using taxol comprising administering granulocyte colony-stimulating factor to the host being treated with taxol. The present inventive method allows for increased levels of taxol to be administered to the host in the treatment of various conditions, particularly with respect to ovarian tumors.|
|Inventor(s):||Reed; Eddie (Germantown, MD), Kohn; Elise (Olney, MD), Sarosy; Gisele (Silver Spring, MD)|
|Assignee:||The United States of America as represented by the Department of Health (Washington, DC)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.